|
Demographics
|
|
Age: Mean (S.D.)
|
49 (9)
|
49 (9)
|
0.98
|
|
Male gender
|
90 (90%)
|
35 (92%)
|
0.71
|
|
Race
|
Black/African-American
|
52 (52%)
|
17 (45%)
|
0.09
|
|
Hispanic/Latino
|
46 (46%)
|
17 (45%)
|
|
Other2
|
2 (2%)
|
4 (11%)
|
|
HIV variables
|
|
VL suppressed at care initiation
|
29 (29%)
|
22 (58%)
|
< 0.01
|
|
Recent HIV diagnosis3
|
19 (18%)
|
2 (5%)
|
0.04
|
|
Reported years diagnosed with HIV4 (S.D.)
|
11.0 (9.5)
|
14.8 (8.7)
|
0.03
|
|
On ART during follow-up
|
90 (90%)
|
37 (97%)
|
0.18
|
|
HIV risk factor
|
Heterosexual
|
58 (58%)
|
20 (53%)
|
0.57
|
|
MSM5
|
33 (32%)
|
2 (5%)
|
< 0.01
|
|
Injection drug use
|
12 (12%)
|
20 (53%)
|
< 0.01
|
|
Transfusion
|
1 (1%)
|
0 (0%)
|
N/A
|
|
Unknown
|
1 (1%)
|
4 (11%)
|
< 0.01
|
|
Comorbidities
|
|
Chronic illness6
|
67 (67%)
|
24 (63%)
|
0.67
|
|
Hepatitis C infection
|
19 (19%)
|
25 (66%)
|
< 0.01
|
|
Current substance use disorder
|
24 (24%)
|
22 (58%)
|
< 0.01
|
|
Current opioid use disorder7
|
12 (12%)
|
21 (55%)
|
< 0.01
|
|
Current cocaine use disorder
|
5 (5%)
|
8 (21%)
|
< 0.01
|
|
Current alcohol use disorder
|
9 (9%)
|
5 (13%)
|
0.47
|
|
Psychiatric illness8
|
39 (39%)
|
20 (53%)
|
0.15
|
|
Chronic non-malignant pain9
|
39 (39%)
|
21 (55%)
|
0.09
|
|
Current smoking
|
41 (41%)
|
30 (79%)
|
< 0.01
|
|
Receiving buprenorphine maintenance treatment
|
2 (2%)
|
11 (29%)
|
< 0.01
|
|
Receiving prescription opioid analgesics10
|
21 (21%)
|
3 (8%)
|
0.08
|